RxDoctor Payments Data

William Southworth, MD

Cardiovascular Disease · Farmington, Mo, MONPI 1265499347

Payments from drug & device makers

$337in general payments, 2019–2025

Across 25 payments — averaging $13.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$83
  • Johnson & Johnson$66
  • Amarin Pharma, Inc.$50
  • Esperion Therapeutics, Inc.$40
  • Sanofi-aventis U.S. LLC$29
  • E.r. Squibb & Sons, L.L.C.$28
  • plus $42 from 2 others

What the payments were for

  • Food & beverage$337100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$337 in reported general payments places this provider in the 20th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri

Medicare billing

Part B allowed, 2024
$53,586
Medicare patients
224
Services billed
1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban245$229,357
XareltoRivaroxaban93$101,360
JardianceEmpagliflozin105$93,885
EntrestoSacubitril/Valsartan70$73,946
Repatha SyringeEvolocumab23$15,994
OzempicSemaglutide11$8,743
Metoprolol Succinate506$5,283
Potassium Chloride352$5,005
Ezetimibe195$4,529
Atorvastatin Calcium500$4,054
Irbesartan251$3,532
Eplerenone76$3,529
Rosuvastatin Calcium298$3,418
Nebivolol Hcl30$2,367
Valsartan27$2,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$66$101,36093 claims
Boehringer IngelheimJardiance$27$93,885105 claims
NovartisEntresto$83$73,94670 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 391 cardiovascular disease providers in Missouri.

Other cardiovascular disease in Farmington, Mo

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →